Europe
Chi-Med Highlights HMPL-689 Clinical Data to be Presented at the 62nd ASH Annual Meeting
… analysis of the first in human HMPL-689 Phase I dose … Europe, with patient enrollment underway. Chi-Med currently retain all rights to … 7340 (Mobile) bmiles@troutgroup.com Europe – Ben Atwell…

